Abstract
Pumping of the heart is powered by filaments of the motor protein myosin, which pull on actin filaments to generate cardiac contraction. In addition to myosin, the filaments contain cardiac myosin-binding protein C (cMyBP-C), which modulates contractility in response to physiological stimuli, and titin, which functions as a scaffold for filament assembly1. Myosin, cMyBP-C and titin are all subject to mutation, which can lead to heart failure. Despite the central importance of cardiac myosin filaments to life, their molecular structure has remained a mystery for 60 years2. Here, we have solved the structure of the main (cMyBP-C-containing) region of the human cardiac filament to 6 Å resolution by cryo-EM. The reconstruction reveals the architecture of titin and cMyBP-C and shows how myosin’s motor domains (heads) form 3 different types of motif (providing functional flexibility), which interact with each other and with titin and cMyBP-C to dictate filament architecture and function. A novel packing of myosin tails in the filament backbone is also resolved. The structure suggests how cMyBP-C helps generate the cardiac super-relaxed state3, how titin and cMyBP-C may contribute to length-dependent activation4, and how mutations in myosin and cMyBP-C might disturb interactions, causing disease5,6. The reconstruction resolves past uncertainties and integrates previous data on cardiac muscle structure and function. It provides a new paradigm for interpreting structural, physiological and clinical observations, and for the design of potential therapeutic drugs.
The heartbeat results from interaction between myosin and actin, present in the heart as organized arrays of protein filaments that slide past each other to produce contraction. After each beat (systole), the heart enters a relaxed state (diastole), leading to filling of the chambers with blood before the next contraction, a process that continues, without break, for the entire lifespan. Contraction is modulated by modifications to the myosin and actin filaments brought about by external stimuli.
Cardiac myosin (“thick”) filaments are bipolar polymers of myosin II7, whose α-helical tails, composed of proximal subfragment 2 (S2) and distal light meromyosin (LMM), form the filament backbone, and paired heads lie at the surface1,2,8,9. Each head consists of a motor domain (MD), essential light chain (ELC) and regulatory light chain (RLC). Three-fold symmetric “crowns” of heads form quasi-helices with a repeat of 430 Å (Fig. 1a). Two myosin-binding proteins are also present. cMyBP-C binds at nine 430 Å-spaced sites in the middle region of each half filament, forming the C-zone, while strands of the giant protein titin run along each half-filament, from the tip to the filament center (Fig. 1a). Titin and cMyBP-C consist of strings of globular, immunoglobulin-like (Ig) and fibronectin-type-III-like (Fn) domains that interact with myosin heads and tails to define thick filament architecture (titin) and regulate myosin function (cMyBP-C)1.
During diastole, myosin filaments are switched off by intramolecular interaction of their paired heads (Blocked Head, BH, and Free Head, FH10), forming interacting-heads motifs (IHMs) that consist of the two interacting heads folded back onto, and interacting with, S2 (Fig. 1b)11,12.The IHM is found in muscle and nonmuscle cells across the animal kingdom13. Sequestration of myosin heads by the IHM appears to underlie the super-relaxed (SRX) state of myosin3, most highly developed in the C-zone14, in which ATP turnover is highly inhibited, conserving energy and providing a reserve of myosin heads for increased physiological demand15. cMyBP-C and the myosin RLC are both phosphorylated in response to stimulation, leading to enhanced contractility1.
Myosin, cMyBP-C, and titin all exhibit mutations that can cause dilated or hypertrophic cardiomyopathy (DCM or HCM), leading to heart failure1. HCM is typically associated with mutations in myosin and cMyBP-C, while titin is the most commonly-mutated protein in genetically-associated DCM. Myosin mutations frequently occur in the IHM interfaces, disrupting head-head interactions and the SRX state, and leading to the observed hypercontractile phenotype5,6. Mavacamten, recently approved by the FDA for treatment of HCM, stabilizes the IHM and SRX16.
Despite the essential importance of the myosin filament to normal cardiac function and disease, its molecular structure remains poorly understood after 6 decades of research. We have determined the three-dimensional (3D) structure of the human ventricular filament C-zone at 6 Å resolution, revealing in molecular detail the complex organization of myosin heads, tails, titin and cMyBP-C. The structure provides solutions to past controversies and a new paradigm for interpreting studies of cardiac structure and function.
Structure of C-zone at 6 Å resolution
We carried out a single-particle 3D reconstruction of the 430 Å repeat unit of the C-zone of native, frozen-hydrated, human ventricular myosin filaments (EM Data Bank codes EMD-29722, EMD-29726, EMD-29734). Global resolution was ~6 Å (6-fold better than previous negative stain reconstructions17,18) and locally as high as 4.5 Å (Extended Data (ED) Fig. 1; ED Table 1). The 3-fold symmetric reconstruction comprised 9 pairs of myosin heads on the filament periphery, segments of ~33 myosin tails in the backbone, with 3 cMyBP-Cs and six 11-domain titin strands on its surface: a total of 123 polypeptide chains and a MW of ~ 5.9 MDa (Protein Data Bank (PDB) code 8G4L; Fig. 1b–g; Supplementary Video 1). We first identify these different components, then discuss the interactions between them that create the complex and underlie its function.
Myosin heads.
Myosin head pairs were clearly recognized as IHMs forming three distinct “crowns”: CrD, CrT, CrH, named for their appearances (Fig. 1b; ED Fig. 2 for abbreviations), arranged in triplets in a 3-start quasi-helical array17,18. These correspond to crowns 2, 3 and 1, respectively, in the accompanying paper by Tamborrini et al.19 (ED Fig 2a). In each 430 Å triplet, the IHM proximal to the bare zone was weak and noisy, suggesting significant dynamic disorder (mobility) of the IHM (CrD, Disordered; Fig. 1b, ED Fig. 1). IHMs in the two more distal crowns were strong, but differed in orientation (dashed lines, Fig. 1b): CrT was tilted (similar to CrD tilt), while CrH was near horizontal (rotated 20° clockwise compared with CrT). Azimuthal rotations between crowns in a triplet, measured to the head-tail junction of each IHM18, were 32° from CrD to CrT and 16° from CrT to CrH, while the rotation between triplets was 72° (CrH to CrD); there were small differences in axial spacing between crowns. Preliminary docking showed that all 3 crowns fitted well with a tarantula-based “canonical” IHM20 (PDB 5tby), supporting the hypothesis that the overall structure of the IHM is conserved across animal evolution13. However, the different tilts and stabilities of IHMs in the 3 crowns, and their distinct molecular environments (due to interactions with other components, described later), suggest diverse functional capabilities—contrasting with invertebrates, where all IHMs are in equivalent environments11,21. Final docking (see Methods) was carried out by flexible fitting of X-ray crystallographic and AlphaFold structures for the heads and tails to generate an atomic model (PDB 8G4L; Fig. 2) that was used in subsequent analysis. Strikingly, IHMs were 40 Å further from the filament axis than in previous negative stain reconstructions17,18 (ED Fig. 3a–d), consistent with recent X-ray modeling of intact muscle22. Agreement of X-ray and cryo-EM data suggests that the reconstruction closely resembles the filament structure in situ, highlighting its relevance to in vivo cardiac physiology.
Myosin tails.
To examine the filament backbone, we extended the reconstruction to 14 crowns (Fig. 3a; see Methods), sufficient to reveal full-length myosin molecules, and focused on their organization in one of the 3 equivalent 120° sectors (ED Fig. 2c). Myosin tails, well-resolved from each other, and measuring ~1590 Å in length, consistent with sequence analysis23, were unambiguous, from N- to C-terminus, due to the characteristic left-handed super-coiling of their paired α-helices (Figs. 1–3, ED Fig. 4, Supplementary Video 2). Crossovers of the two helices were typically ~75 Å apart, but longer (100–110 Å) in the regions containing the 4 skip residues (T1188, E1385, E1582, G1807), where the coiled-coil α-helices became more parallel. The skips in all 3 tails also appeared to be associated with bends in the tail, consistent with distortion of coiled-coil structure by skip residues, although these differed between the 3 tail types (ED Fig. 4h, i; Supplementary Video 3)23,24.
The tails showed no sign of association into subfilaments25, nor did they follow a “molecular crystal” arrangement26 demonstrated in invertebrate filaments21, where all tails have equivalent environments: vertebrate filaments have a unique tail organization not predicted by any previous model. Tails started (as S2) at the junction of the heads of each IHM, but then followed 3 quite different paths to their C-termini, depending on their crown of origin (Fig. 3, ED Fig. 4, Supplementary Video 2). CrH tails dipped initially toward the filament backbone, then reverted toward the surface (near skip 2, ~755 Å from its origin; ED Fig. 4i). CrT tails started similarly, in contact with CrH tails, but then stayed at low radius, forming the inner cylindrical core of the backbone (Fig. 3, ED Fig. 4). CrD tails were completely separate, always near the filament surface, where they made many interactions with cMyBP-C and titin. Their S2 regions had a flattened appearance (red/orange tails, Fig. 1c, d), suggesting vibrational motion parallel to the plane of flattening, consistent with the dynamic disordering (mobility) of the CrD heads. The different courses of the 3 types of tail thus correlate with the specific crowns from which they originate, possibly contributing to functional specialization of these crowns, enabling a flexible response to physiological demand. Such specialization represents an evolutionary increase in complexity over the invertebrates, with their simple arrangement of myosin, in which all molecules are structurally equivalent, in a strictly helical organization, which would produce a more stereotyped response11,21. The unexpectedly complex, non-equivalent arrangement of tails in the native vertebrate filament suggests caution in interpreting structure/function in synthetic filaments made from purified myosin.
Titin and cMyBP-C.
In association with myosin, strings of ellipsoidal subunits, ~40 Å long, ran along the backbone surface, suggestive of the linear arrangement of globular, ~10-kDa, Fn and Ig domains in titin and cMyBP-C27–31 (Fig. 1). In each 120° sector (ED Fig. 2c, e), two 11-domain strands ran parallel to and in register with each other, consistent with the two strands of titin’s 11-domain 430-Å C-zone super-repeat (Ig-Fn-Fn-Ig-Fn-Fn-Fn-Ig-Fn-Fn-Fn) and its stoichiometry of 6 molecules per half filament; we refer to these as titin A and titin B (TA and TB) (Figs. 1, 2, ED Figs. 2e, 5, 6). The two strands do not appear to interact, except at two intermolecular contacts, Ig domains T1 and T8 (Fig. 4d), marking the junction between sectors. Their flexible path, kinked at each Ig domain, is consistent with short, pliant linkers between domains28, but there is no evidence for extended dimerization or helical twisting of strands about each other28,32 (Figs. 1, 2, ED Fig. 6). We also observed a single strand with 6 subunits, consistent with the C-terminal half (C5–C10) of cMyBP-C, which includes domains C8–C10, thought to anchor cMyBP-C to the filament backbone (Figs. 1, 2)30. We validated these interpretations, and uniquely identified each domain of cMyBP-C and titin, using AlphaFold (ED Fig. 5, Methods, Supplementary Methods, Supplementary Figs. 1, 2, Supplementary Video 4). Our interpretation, based only on structure, predicts that both titin and cMyBP-C have their C-termini closer to the M-line, directly verifying previous conclusions from sequence analysis and antibody labeling33,34.
In summary, the reconstruction fully accounts for the major known components in the C-zone of the vertebrate thick filament and reveals their organization at high resolution.
Interactions between components
Specific interactions between components are central to creating a biomolecular complex and determining its function. Myosin, titin, and cMyBP-C all have multiple domains and extended structures, making numerous interactions possible. Many have been inferred from studies over 6 decades. Our reconstruction reveals the major interactions in the native filament (ED Fig. 2), including numerous contacts of myosin heads with heads, tails with tails, titin with tails, and cMyBP-C with heads and tails—but, unexpectedly, no interaction of titin with myosin heads or with cMyBP-C (Figs. 1, 2, ED Fig. 2). We first describe the tail-tail and titin-tail interactions that determine filament architecture, then the head–cMyBP-C, tail-cMyBP-C and head-head interactions that define its function.
Myosin tails form an interacting network.
Interaction between tails is well-known to underlie myosin filament formation, through charge-charge attraction. Muscle X-ray patterns35, EM of myosin tail paracrystals2, and sequence analysis23 suggest important tail staggers of ~143 Å and 430 Å, arising from a periodic charge repeat every 28 residues (42 Å) along each tail: attraction is predicted between tails displaced by ~(n + ½) × 28 residues (n integral)23. The reconstruction shows that, within one triplet of IHMs (CrD-CrT-CrH), interacting CrH and CrT S2s are staggered by ~140.6 Å, directly revealing the predicted charge attraction for a 95–96 residue (141–143 Å) stagger of S2s23 (ED Figs. 4g, 7a). But the full network of tail interactions occurs only when tails from axially neighboring triplets contact each other (Fig. 3a–c, ED Figs. 4a–f). A key example is the merging of the light meromyosin (LMM) regions of three CrT tails from one triplet with three from the next, creating the cylindrical core described earlier (Fig. 3, ED Fig. 4a, b, e). This type of interaction, with a 430 Å stagger between tails of the same type, is the most common in the reconstruction, occurring also with CrH and CrD tails (ED Figs. 4a (neighboring tails with crown number differing by 3); 4e). It is made possible because crowns of the same type, 430 Å apart, have the same azimuthal and radial positions, placing their tails close enough for mutual electrostatic interaction23 (ED Fig. 4g). Interactions between tails from different crown types (CrH-CrT, CrT-CrD, CrD-CrH) also occur, less frequently, when staggered by 5 or 7 crowns (715 or 1001 Å; ED Fig. 4d,f), as predicted by sequence analysis23. The 3-, 5- and 7-crown staggers between tails all involve the distal region of LMM (ED Figs. 4d–f), which includes the C-terminal assembly competence domain (ACD, residues 1871–1899; Supplementary Fig. 3), consistent with its essential role in filament formation36. These varied tail interactions, differing depending on crown of origin, and localized to specific points along the tails, contrast with the simpler, helical invertebrate backbone, where all myosin molecules are equivalent, and tails interact along most of their length21.
Titin dictates assembly of tails.
The above tail network is only possible if myosin molecules are placed at particular positions axially, azimuthally, and radially. Our data suggest that this occurs through their positioning by titin, with its 430 Å super-repeat functioning as a C-zone template27. The two titin strands in each sector show numerous interactions with myosin tails, mostly CrH and CrD, and a few with CrT (Fig. 4a–c; Supplementary Video 5). Both Ig and Fn titin domains are involved. CrH S2 interacts with all 11 domains of titin A via attraction of the ~40-Å–spaced +/− charge repeat on S223 to complementary charges on the ~40-Å–spaced titin domains (ED Fig. 7b). LMM of the CrH tail also interacts with titin A, and to a similar extent with titin B (Fig. 4c). Titin’s positioning of CrH myosins 430 Å apart is reinforced by the 430-Å–staggered tail-tail charge interactions described above23 (ED Fig. 4g). In contrast to CrH, CrT tails interact little with titin, being positioned instead by the ~140-Å-staggered electrostatic attraction of CrT S2 to CrH S2 described above (Fig. 3e, ED Figs. 4g, 7a). The extensive interaction of CrH (and to a lesser extent CrT) tails with TA occupies many TA binding sites; in fact, an individual titin domain may bind as many as 3 tails around its surface (Fig. 4e). This may explain the need for a second titin (TB) in each sector, to position CrD tails (Fig. 4c). This interaction, with S2 of CrD (Fig. 4c), occurs in the middle sections of two TB super-repeats (T4–T7), which are rotated ~90° relative to TA (between kinks at T3/T4 and T7/T8), placing this region at higher radius (ED Fig. 6a, b), and with different titin binding sites exposed. This may explain CrD tails forming the outer shell of the backbone (ED Fig. 4a), their axial displacement from CrT, and the greater distance of CrD heads from the filament surface. As CrH and CrT tails interact with the same titin (TA), CrH is close to CrT azimuthally. In contrast, the interaction of CrD with TB, where TB and TA in the same titin pair are ~48 Å apart, explains the large azimuthal rotation (~72°) from CrH to CrD of the next triplet (ED Fig. 6d).
Compared to the extensive interaction of titin with myosin tails, we see no interaction with myosin heads. This supports some in vitro studies of purified proteins37, but contradicts others, which concluded that titin binds to myosin mainly through the heads38. The reason for the discrepancy between previous in vitro data is unclear, but comparison with our observations suggests caution in using such data to decipher native structure.
In summary, we see the detailed course of all 11 domains of both titin strands, which position the myosin tails in a unique network arrangement, whose interactions are reinforced by electrostatic tail-tail interactions first predicted 40 years ago.
cMyBP-C binds tails, heads but not titin.
cMyBP-C30 is a modulator of myosin activity in the C-zone, where it is thought to enhance myosin’s SRX state14,39, modulated by phosphorylation of the M-domain40. With no previous high-resolution information on its organization, it has remained a mystery how cMyBP-C, with a ratio of only one to every 3 myosins in a 430-Å repeat, could affect the activity of multiple myosins40. The longitudinal orientation of cMyBP-C domains C5–C10 produces interactions with myosins from 6 different crowns (Fig. 5): the FH motor domains in crowns H and T and CrH FH RLC (Fig. 5c–f), S2 from the next CrT distal to the M-line (Fig. 5b), and a complex of LMM tails from 3 CrD crowns (Fig. 5b, c, ED Fig. 8; Supplementary Video 6). These interactions are consistent with in vitro studies demonstrating MyBP-C binding to S1, S2 and LMM6,30,40, but show that in the native filament, the interactions are confined to specific myosins. There is no evidence for a circumferential arrangement of cMyBP-C30, nor for interaction of a folded cMyBP-C conformation with the IHM6. Strikingly, the heads interacting with cMyBP-C are those of the two well-ordered crowns (specifically the FHs of CrH and CrT), suggesting that cMyBP-C contributes to this ordering, possibly stabilizing their IHM/SRX state and tethering them to the backbone.
In contrast with the longitudinal orientation of cMyBP-C’s C-terminal half, there is evidence that, in the sarcomere, its N-terminal domains extend away from the thick filament and bind to thin filaments19,41. In our preparation of thick filaments—lacking thin filaments—the N-terminal half of cMyBP-C is likely to be mobile, enabling it to bind weakly to the thick filament40. Our reconstruction supports this. At low contour cutoff, clear but weaker density is seen for domains C4, C3 and C2, loosely resting on S2 of the more distal CrT (Fig. 5g) and with possible contact of C4 with the CrD BH (Fig. 5g, white circle). While the most N-terminal domains (C0, C1 and M) are not visible as discrete subunits, they may contribute to additional weak density on the FH of CrD (Fig. 5g, yellow arrows).
In vitro, cMyBP-C’s N-terminal domains C0–C2 can interact with both myosin and actin, implying possible switching between thick and thin filaments in different muscle states40. This is supported by X-ray diffraction of muscle at different sarcomere lengths42 suggesting that when thin filament binding sites are present (overlap zone of the sarcomere), N-terminal binding to actin produces the well-known 430-Å–spaced cMyBP-C stripes in the C-zone, but when absent (isolated filaments, sarcomeric H-zone), the N-terminal region is mobile. The weakness of thick filament/N-terminal binding in our reconstruction may be due to partial M-domain phosphorylation in our preparations (Fig. 5), weakening binding to the filament40. Remarkably, the mobile region of cMyBP-C appears to be mainly at the level of the dynamically disordered—possibly “disordered-relaxed” (DRX40)—heads (CrD). These two regions might cooperatively guide each other to their interaction sites on the thin filament when present. This location suggests that cMyBP-C’s most important functional region (C0–C2) would impact primarily CrD heads, for example upon M-domain phosphorylation, or loss of the N-terminal 29 kDa region through proteolysis during ischemia40.
Based on binding studies, it is widely assumed that titin positions cMyBP-C on the thick filament through interaction of its C-terminus (C8–C10) with the first Ig domain of titin’s 11-domain super-repeat43. Surprisingly, we see no contact of cMyBP-C with titin: the two are clearly separated by a CrD tail (Figs. 1, ED Fig. 2a). Instead, cMyBP-C appears to dock onto the backbone by electrostatic binding of its C-terminal region to a sheet of 3 CrD tails lying side-by-side, originating from three consecutive 430 Å repeats (Fig. 5a–f; ED Fig. 8). Possibly, the C-terminal cMyBP-C interaction with titin seen in vitro occurs during filament assembly, but is lost in the mature filament; alternatively, titin determines cMyBP-C position indirectly, by dictating the positions of the CrD tails, as suggested by the reconstruction. Strikingly, C10 of cMyBP-C in the reconstruction aligns precisely with T1 of titin, while C8 and C9 extend over T9 and T10 of the next, more distal super-repeat (Fig. 1g). This agrees closely with conclusions from antibody labeling34,44, providing strong support for our interpretation based on structure alone.
Division of the thick filament into C- and D-zones has been known for 40 years, but never satisfactorily explained1,27,40. It is usually attributed to the presence of cMyBP-C binding sites in titin’s C-zone 11-domain super-repeat that are absent from the 7-domain super-repeat of the D-zone27,40. But this explanation fails if cMyBP-C does not bind to titin. The binding of cMyBP-C to the specific coalescence of CrD tails from three 430 Å repeats (ED Fig. 8), themselves positioned by titin’s 430-Å 11-domain super-repeat, would explain why cMyBP-C is confined to the C-zone, as this organization of tails would be absent from the 7-domain super-repeat of the D-zone. It would also explain why cMyBP-C is unexpectedly absent from the first two 430-Å titin repeats (those closest to the Z-line)34, starting instead ~720 Å closer to the M-line44—because the full set of three 430-Å levels of CrD tails is required for cMyBP-C to bind.
In summary, cMyBP-C binds to myosin heads and tails, but not to titin. Its interactions, seen in the context of the native thick filament, suggest how it may modulate myosin activity, differently in different crowns, with fine-tuning by phosphorylation. Its longitudinal binding shows that in the absence of actin, as in our preparation, its N-terminal half (in addition to its C-terminal half) can bind to myosin, which has not been previously demonstrated structurally. Combined with evidence for actin binding, this provides strong support for models in which cMyBP-C’s N-terminal can switch binding partners, depending on actin-availability and muscle physiological state40.
IHM interactions modulate head activity.
The reconstruction shows that, in addition to interacting with cMyBP-C, myosin heads interact with each other and with myosin tails. Within the IHM, the BH and FH motor domains form a large interaction interface, and the BH interacts with S2, as in the canonical IHM of invertebrates20. These intramolecular interactions are thought to stabilize the SRX state of myosin heads in an inhibited (locked) conformation45. They can be studied at highest resolution by cryo-EM of isolated IHMs in solution46, which we find are very similar to CrH and CrT of the filament (ED Fig. 3h, i). However, small differences in CrH and CrT IHMs (Fig. 2h) and small differences from the solution structure mean that isolated IHMs cannot precisely reproduce intramolecular interactions in all crowns of the native filament. For example, in the native filament the IHM structure adapts to different crown environments through CM-loop flexibility, either binding to its own S2 or to another tail (Fig. 6g–i, ED Fig. 9d).
In addition to intramolecular interactions, contacts between IHMs appear likely along their quasi-helical tracks. These interactions, absent in studies of individual molecules, may involve unstructured N-terminal regions of the ELCs and RLCs (Fig. 6)46. CrD, CrT and CrH form a triplet (Fig. 6a, b), in which CrT and CrD are both tilted, such that the N-terminal residues of CrD BH ELC could contact the CrT FH SH3 domain below18 (Fig. 6b,c)—as in tarantula, where all IHMs are also tilted11. Intramolecular interaction of the N-terminal ELC with myosin SH3 has been previously suggested in vitro47. Our reconstruction indicates that, in the thick filament, inter-molecular interaction is possible. A key innovation in vertebrate thick filament evolution may be the 20° clockwise rotation of the CrH IHM relative to CrT (see Myosin heads, above; Fig. 1b). This brings CrH’s FH within range of the proximal CrT N-terminal BH RLC18 (Fig. 6b, d). Although no density is visible for the mobile RLC N-terminus, AlphaFold predicts that this positively charged region (1-MAPKKAKKR-9) could reach, and possibly interact with, the cavity formed by 8 negatively charged amino acids (5 Asp and 3 Glu) of this FH (Fig. 6d, e), possibly impacting phosphorylation of Ser15 of the CrT BH RLC by affecting its accessibility to MLCK. The different interactions between CrD, CrT and CrH in a triplet (Fig. 6a–f) could enhance the functional plasticity of myosin over that in tarantula, where all crowns are equivalent11,12—a possible physiological advantage. We also observe density for the N-terminal extension of the FH RLC (disordered in myosin head crystal structures), apparently stabilized by electrostatic interaction with the BH RLC (Fig. 6f). Phosphorylation on Ser15 would be likely to break this interaction, releasing the CrH FH (Fig. 6f).
These contacts between CrD, CrT and CrH within a triplet suggest a physical communication pathway between crowns, which could contribute to cardiac function through local cooperative thick filament activation. Contact between triplets seems unlikely (CrH ~ 50 Å from the next most distal CrD), suggesting that triplets would function as individual cooperative units, responding independently to mechanical changes or signaling events. This would augment the versatility of response implied by the structural differences between crowns within a triplet.
There are also interactions between the heads and the tails. CrH and CrT FHs interact with the same CrD tail from 2 triplets distal, via α-helices in their motor domains (Fig. 6j, k, m). The CM-loop of CrT-FH interacts with its own S2 (Fig. 6g, i), while that of CrH-FH interacts with the tail of the more distal CrT (Fig. 6g, h; ED Fig. 9d). The converter of CrT-BH also comes close to S2 of the next CrH (Fig. 6j, l). We suggest that these inter-IHM, IHM-tail (and also IHM-cMyBP-C) interactions together contribute to stabilization of SRX in the C-zone and may play a dominant role in filament activation (see Physiological and clinical implications, below).
Structural consequences of mutations
Over 250 mutations in the myosin heavy chain, light chains, MyBP-C and titin are known to be pathogenic or likely pathogenic in humans, leading to HCM and DCM1,5. Mapping these mutations on to the reconstruction suggests their likely structural impact. In summary, we confirm the clustering of mutations in the intramolecular interaction interfaces of the IHM suggested previously (based on a low-resolution homology map of the tarantula thick filament), which were proposed to weaken the IHM, impair relaxation and increase energy consumption, leading to HCM pathogenesis5,6. A full analysis will be presented elsewhere. Here we highlight 4 representative examples of new or previously unexplained clusters of HCM mutations (mostly charge reversal or neutralization), whose locations in our map reveal their involvement in key, functionally important intermolecular interactions between myosin heads, tails, titin, and cMyBP-C. Strikingly, the different structures and interactions of the different crowns, and of the different heads (BH, FH) within them, means that a single mutation can have distinct effects at as many as 6 locations, or only affect one specific interaction (ED Fig. 9). Mutations E924K and E930K in ring 248 of CrD S2, at its interface with titin B (ED Fig. 9a), could weaken CrD binding to the filament and alter transmission of tension by titin to cMyBP-C, thus disturbing length-dependent activation (see next section). The same mutation (E924K) in a different (CrT) tail, at its interface with the CrH tail (ED Fig. 9b), could have a quite different effect, destabilizing docking of the CrT IHM onto the filament, impairing its SRX state. Mutations in either cMyBP-C or myosin, at the C8/CrH FH interface (ED Fig. 9c), could disrupt CrH FH stability and thus its SRX state. Finally, a classic mutation in the cardiomyopathy loop of the myosin head (R403Q) could have quite different effects depending on whether it occurs in the FH or BH5 and whether it is in CrH or CrT. On the CrT FH it could alter binding of the FH to its own S2, while on the CrH FH, binding to CrT S2 would be affected (ED Fig. 9d). All of these disturbances are potential causes of HCM. We found no mutations in regions involving interactions between crowns.
Physiological and clinical implications
Our reconstruction reveals the high-resolution structure and complex set of molecular interactions that underlie thick filament function in the human heart. A similar structure is likely in skeletal filaments, and across all vertebrates, based on their similar X-ray diffraction patterns35,49, making this a new paradigm for vertebrate thick filament structure. The reconstruction provides many new insights into the organization, energetics, function, and consequences of mutations in the cardiac thick filament. Three types of IHM characterize the C-zone, with different tail paths and different interactions. CrH and CrT are stabilized by cMyBP-C and likely represent SRX heads, while CrD IHMs are more mobile (DRX). The latter, along with mobile heads in the D-zone, may function as “sentinel” heads that detect thin filament activation and create initial tension in systole14,50. FHs are likely more stable than BHs, due to their greater number of interactions—the opposite of tarantula51. The flexible, finely-tuned response made possible by these different IHMs, with modulation by RLC and cMyBP-C phosphorylation, represents a major evolutionary innovation over invertebrate thick filaments. Lacking titin and cMyBP-C, and having a uniform set of tail and head interactions11,21, invertebrate filaments would have a more stereotyped response for all molecules. Our structure suggests a plausible model for thick filament assembly in vivo, in which titin is laid down first27 and recruits myosin II and finally MyBP-C into nascent filaments (Supplementary Discussion).
The heart must pump out what it takes in, and has developed a sophisticated mechanism for doing so. The Frank-Starling law is an auto-regulatory, beat-by-beat mechanism that adjusts the strength of contraction in systole to the amount of blood in the ventricles in the preceding diastole4. A fundamental concept of cardiology, it is equivalent at the cellular level to length-dependent activation (LDA): a longer cardiac sarcomere contracts more strongly than a shorter one. Numerous proposals have been made to explain LDA. Recent experiments suggest that activation of myosin heads (e.g. from SRX to DRX state) through increased stress on the thick filaments, transmitted passively via titin at longer sarcomere length, plays a key role49,52. Our reconstruction reveals a simple molecular pathway involving titin, myosin and cMyBP-C, that could explain this mechanism (ED Fig. 10). In this model, stretching of the sarcomere at end-diastole transmits tension via I-band titin to titin strands in the thick filament. TB and TA both exhibit spring-like kinks (ED Fig. 6) that could be straightened under tension, causing CrD tails, attached to TB (Fig. 4c), to slide past each other, partially disrupting cMyBP-C’s main backbone binding site (Fig. 5b, c, ED Fig. 8). This could disturb cMyBP-C’s stabilizing interactions with myosin heads, shifting the equilibrium from SRX towards DRX52. Additional CrH and CrT heads thereby made available for actin interaction would account for the enhanced systolic force that follows. Active force generated by myosin heads during systole, stretching the filament by up to 1.6%, may produce similar changes in CrD tails, cMyBP-C, myosin heads and titin, disrupting their interactions to explain thick filament activation by mechanosensing in both cardiac53 and skeletal muscles54.
Our structure has important clinical relevance. Filaments were prepared in the presence of mavacamten, an FDA-approved drug used to treat HCM-based hypercontractility, by stabilizing the SRX/IHM of myosin heads16: we are therefore observing the structure of filaments as they might be in mavacamten-treated patients. We used mavacamten to enhance the resolution of our structure, but based on previous low-resolution reconstructions17,18 and X-ray data16 it should not significantly alter the structure of the filament. Mavacamten has enabled new, high-precision insights into the structure and function of the native human cardiac filament and possible mechanisms of disease. Our structure unlocks the door to future planning of drug targets.
Methods
Research ethics for donated tissues
Tissue samples collected from the University of Kentucky (samples 5155D, 53018.4; 78952, 53132.3, and D0F54, 52902.3) were processed by the Gill Cardiovascular Biorepository. All samples came from the outer third of the left ventricular free wall. They were obtained from terminal organ donors whose hearts could not be used for transplantation for technical reasons (e.g. blood type mismatch). The local Organ Procurement Organization (Kentucky Organ Donor Affiliates, KODA) obtained informed consent from the legally authorized representatives, which allowed the hearts to be used for research if they could not be used as part of clinical care. All procedures were approved by Kentucky Organ Donor Affiliates and the University of Kentucky IRB.
Myosin filament preparation
Cardiac ventricular tissue samples collected by technical staff in the operating room were immediately placed into cold saline, then taken to the lab for dissection into anatomic regions. They were flash-frozen in liquid nitrogen and stored in its vapor phase (see Blair et al. for further information56). Samples were sent on dry ice from University of Kentucky to University of Massachusetts Chan Medical School, and stored at −80°C. Myosin filaments were isolated from ventricular tissue under relaxing conditions. All steps were performed at room temperature (24°C). Chemicals were purchased from Sigma. A piece of frozen muscle (~120–150 mg) was thawed by placing in relaxing solution (100 mM Na acetate, 8 mM MgCl2, 5 mM NaATP, 1 mM EGTA, 2 mM imidazole, 10 mM phosphocreatine, pH 6.8) with protease inhibitors (Leupeptin, Pepstatin and Aprotinin, 0.004 mg/mL each), and chemically skinned in relaxing solution containing 0.5% Triton X-100 for 30 min with agitation. The muscle was cut into small pieces and teased with forceps to make fine bundles8, which were further relaxed with fresh relaxing solution for 90 min. Relaxed bundles were treated with 0.25 mg/mL Porcine Pancreatic Elastase (Sigma, E0127, Type III)8 for 3 min, followed by addition of 1 mM PMSF for 10 min to stop the reaction. A filament homogenate was produced by gentle hand shaking for 3 min to release maximum numbers of myosin filaments, and the sample was clarified by centrifugation (3000 rpm, 3 min). Contaminating thin filaments in the supernatant were fragmented using the N-terminal half of gelsolin57,58 (400 μg/mL), expressed in E. coli using a recombinant plasmid provided by Dr. Christine Cremo (University of Nevada). The resulting myosin filaments were pelleted by centrifugation (14000 rpm, 5 min), and dissolved and gently resuspended in 100 μL fresh relaxing solution containing 50 μM mavacamten. Filament quality was checked by negative staining59 with 1% w/v uranyl acetate before cryo-EM grid preparation.
Use of mavacamten.
Mavacamten was used to stabilize the labile myosin head array and thus enhance the resolution of the reconstruction. X-ray diffraction suggests that it does this without significantly changing myosin head structure16. The overall similarity of myosin head conformation in our structure compared to negative stain reconstructions in the absence of mavacamten17,18 supports this. 2D class averages of negatively stained cardiac filaments with and without mavacamten appear similar to each other (unpublished data), further implying no major change in structure. We avoided glutaraldehyde crosslinking, used in some cryo-EM studies to stabilize structure.
Cryo-EM
3 μL of myosin filaments from the above 100 μL sample were applied to C-flat holey carbon grids (CF-1.2/1.3–3 Au, Protochips) glow-discharged for 45 sec at 30 mA using a PELCO easiGlow (Ted Pella). Grids were rear-side-blotted at 25°C and 95% relative humidity using a Leica EM-GP-2, and plunge-frozen in liquid ethane immediately after blotting. Grids were stored in liquid nitrogen until screening and data collection.
Data acquisition
Grids were initially screened on a 200 keV Talos Arctica (Thermo Fisher Scientific) for ice thickness, filament quality, and filament distribution. Optimal grids were imaged at 300 keV on a Titan Krios (Thermo Fisher Scientific) equipped with Gatan K3 direct electron detector and Gatan GIF Quantum energy filter. Data collection (in counting mode) was performed in three different sessions, using filaments from 3 different hearts. A total of 56,489 movies were recorded (18,516, 18,872, and 19,101, respectively), using SerialEM V 4.060, with 40 frames over 4s for a total electron dose of ~60 e− Å−2. Nominal magnification was 105,000x, with a pixel size of 0.415 Å in super-resolution mode (physical pixel size of 0.83 Å at the specimen level), and a defocus range from −1 to −2 μm.
Data processing
Images were processed using single particle methods; we avoided helical averaging, which would have lowered the resolution, as the filaments are only quasi-helical. Movies from the three Krios sessions were processed separately and the particles from all three sessions combined for final processing. Dose-fractionated movies were motion-corrected using Patch Motion Correction in cryoSPARC 3.3.261. Patch contrast transfer function (CTF) was used in cryoSPARC 3.3.261 for CTF estimation. Initially, the reference-free filament-tracer module in cryoSPARC 3.3.2 was used to pick particles from all dose-fractionated micrographs, and the particles extracted using a box size of 1048 pixels (pixel size 0.83 Å), which included approximately 6 crowns of heads. The 1048-pixel box was Fourier-cropped to 800 pixels to produce a final pixel size of 1.0873 Å. Initial 2D-classification in cryoSPARC 3.3.2 (using 100 classes) resulted in multiple good classes, which were then used for template-based particle-picking. Next, iterative 2D classification was performed, resulting in 104928, 92790 and 149418 curated particles from the 3 Krios sessions, respectively. Particles were combined, and reference-free ab initio reconstructions with 4 classes were generated in cryoSPARC 3.3.2. These were further used as 3D models in heterogeneous refinement, using all selected particles from the 4 classes. The heterogeneous refinement resulted in the following particle numbers: class 0 (102581), class 1 (87325), class 2 (138288), and class 3 (18952). Particles from classes 0 and 2 were further refined using homogenous refinement, resulting in two final reconstructions, containing 102581 and 138288 particles, with estimated resolutions (gold-standard FSC 0.143 criterion) of 6.4 and 6.0 Å respectively (ED Table 1). Local resolution was calculated in cryoSPARC 3.3.2. Maps were post-processed using DeepEMhancer62. Portions of the two final reconstructions containing the two stable crowns (CrH and CrT) were combined using the signal subtraction module in cryoSPARC 3.3.2, followed by 3D classification into 4 classes. 3D classification resulted in the following particle numbers: Class 0: 49227, Class 1: 82458, Class 2: 62747, and Class 3: 46436. Particles from classes 0, 2 and 3 were combined in a homogeneous refinement, resulting in a 2-Crown reconstruction with 158410 particles, showing more detailed secondary structure. A 14-crown extended map was generated by joining multiple 5-crown (CrH-CrT-CrD-CrH-CrT) maps, which were initially superimposed at the last two crowns (CrH-CrT) and first two crowns (CrH-CrT) of two 5-crown maps using the vop maximum command in ChimeraX.
Model building and refinement
For myosin head model building, CrH was initially made from the crystal structure of the bovine β-cardiac myosin head (PDB 5n69), containing the motor domain and ELC region of the regulatory domain, which was rigid-body fitted to the CrH BH and FH of the 2-crown map, using Fit in map in ChimeraX. This was followed by molecular dynamics flexible fitting (MDFF, NAMDINATOR63) and manual building in COOT64. The S2 region was fitted using the crystal structure of the human β-myosin S2 fragment48 (PDB 2fxo). The RLC and its binding region on the lever arm were built using AlphaFold65 structures Uniprot ID P10916 for the RLC (https://alphafold.ebi.ac.uk/entry/P10916) and P12883 for the RLC binding region of the human cardiac myosin heavy chain (https://alphafold.ebi.ac.uk/entry/P12883). The full IHM structure was finally refined using Phenix real space refinement66. To build CrT, the final CrH IHM was flexibly fitted (MDFF, NAMDINATOR) into the segmented density of CrT, followed by Phenix real space refinement. To construct the myosin tails, an initial model was built using AlphaFold Colab65 and then flexibly fitted into the 14-crown map density, based on the 5-crown map (see Data processing), starting from the head all the way to the end, in multiple iMODFIT normal mode refinement67/MDFF cycles, followed by Phenix refinement, as described above. AlphaFold database entry Q14896 (cMyBP-C) (https://alphafold.ebi.ac.uk/entry/Q14896) was used as an initial model for building cMyBP-C. Domains C5 to C10 from the model were fitted to the 5-crown map using MDFF and iMODFIT normal mode refinement (Fig. 2, ED Fig. 5). For titins (TB and TA), titin C-zone 4 sequence (Supplementary Table 1) was used to build the initial model, using AlphaFold Colab. An outstanding rigid body fit to the 5-crown map was obtained with domains T1–T3 (Ig-Fn-Fn) and T8–T11 (Ig-Fn-Fn-Fn), using ChimeraX Fit in Map (ED Fig. 5, Supplementary Methods, Supplementary Figs. 1, 2). The middle domains T4–T7 (Ig-Fn-Fn-Fn) were fitted using flexible fitting (MDFF, NAMDINATOR). All parts were joined using COOT, and full-length TB and TA were refined using a final round of MDFF followed by Phenix real space refinement (Fig. 2, ED Fig. 5). Iterative refinement was cycled between COOT, ISOLDE68 (in ChimeraX) and Phenix real space refinement for the full, 3-crown model. Validation was carried out using Molprobity69. Figures were made using UCSF ChimeraX70.
Model building of CrD.
The full 3-crown atomic model (PDB 8G4L) was built using a cryo-EM map with estimated overall resolution of ~6 Å (ED Fig. 1). Although CrD is mobile, with weaker density and lower local resolution, it too has an average IHM structure (Fig. 1b). We therefore also included an IHM atomic model positioned to fit its overall low-contour density, showing where CrD is positioned (on average) with respect to the 2 stable crowns (CrH and CrT) in a triplet. This was carried out by rigid-body fitting of the CrT IHM atomic model into the CrD density using ChimeraX.
Note: Because our atomic model was based on a 6 Å map, it should not be interpreted at atomic resolution. However, it aids in understanding the overall positions of the total 123 polypeptide chains that make up the 430 Å repeat of the human cardiac thick filament C-zone and the possible interactions between components.
Extended Data
Extended Data Table 1.
Cryo-EM structure of human cardiac myosin filament (EMD-29722) (PDB 8G4L) | Cryo-EM structure of human cardiac myosin filament (EMD-29726) | Cryo-EM structure of human cardiac myosin filament (EMD-29734) | |
---|---|---|---|
Data collection and processing | |||
Magnification | 105,000x | 105,000x | 105,000x |
Voltage (kV) | 300 | 300 | 300 |
Electron exposure (e-/Å2) | 60 | 60 | 60 |
Defocus range (μm) | −1 to −2 | −1 to −2 | −1 to −2 |
Pixel size (Å) | 0.415 | 0.415 | 0.415 |
Symmetry imposed | C3 | C3 | C3 |
Initial particle images (no.) | 1,140,535 | 1,140,535 | 1,140,535 |
Final particle images (no.) | 102,581 | 138,288 | 158,410 |
Map resolution (Å) | 6.4 | 6.0 | 7.9 |
FSC threshold | 0.143 | 0.143 | 0.143 |
Map resolution range (Å) | 2.5–12.9 | 2.3–12.5 | 0–17.3 |
Refinement | |||
Initial model used (PDB code) | 5N69, 2FXO | ||
Model resolution (Å) | 6.6 | ||
FSC threshold | 0.143 | ||
Model resolution range (Å) | 3.7–7.9 | ||
Map sharpening B factor (Å2) | 156.3 | 87 | 559.6 |
Model composition | |||
Non-hydrogen atoms | 416,574 | ||
Protein residues | 51,438 | ||
Ligands | 0 | ||
B factors (Å2) | |||
Protein | 385.56 | ||
Ligand | -- | ||
R.m.s. deviations | |||
Bond lengths (Å) | 0.012 | ||
Bond angles (°) | 0.702 | ||
Validation | |||
MolProbity score | 2.84 | ||
Clashscore | 102.27 | ||
Poor rotamers (%) | 0.01 | ||
Ramachandran plot | |||
Favored (%) | 94.68 | ||
Allowed (%) | 5.32 | ||
Disallowed (%) | 0.00 |
Supplementary Material
Acknowledgments
We thank Drs. Christna Ouch, KangKang Song and Chen Xu for help and training in cryo-EM imaging, Drs. Kyoung Hwan Lee and Greg Hendricks for conventional EM training, and Dr. Niko Grigorieff for use of the Leica EM GP2 plunge freezer. We are grateful to Drs. Tom Irving and Weikang Ma for the unpublished X-ray diffraction pattern of porcine cardiac muscle shown in Extended Data Fig. 3 and Dr. Christine Cremo (University of Nevada) for the gift of gelsolin N-terminal-half plasmid. This work was supported by NIH grants AR072036, HL139883, HL164560, AR081941, HL149164 and HL148785. UCSF ChimeraX, used for molecular graphics, was developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from NIH grant GM129325 and the Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases.
Footnotes
Competing interests
The authors declare no competing interests.
Supplementary Information is available for this paper (Supplementary Methods, Supplementary Discussion, one supplementary table, three supplementary figures, six supplementary videos).
Reporting summary
Further information on research design is available in the Nature Research Reporting Summary linked to this paper.
Data availability
Structural data that support the findings of this study on the structure of the human cardiac thick filament have been deposited in the Electron Microscopy Data Bank. One 2-crown and two 5-crown maps have been deposited, with accession codes EMD-29734, EMD-29722 and EMD-29726, respectively. An atomic model of the full 3-crown structure, with myosin heads, tails, titins, and cMyBP-C, has been deposited in wwPDB with accession code 8G4L. PDB data used to build the model were PDB 5n69 and PDB 2fxo. AlphaFold structures used to build the model were P10916, P12883, and Q14896.
Main references
- 1.Wang L, Geist J, Grogan A, Hu LR & Kontrogianni-Konstantopoulos A Thick Filament Protein Network, Functions, and Disease Association. Compr Physiol 8, 631–709, doi: 10.1002/cphy.c170023 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Huxley HE Electron microscope studies on the structure of natural and synthetic protein filaments from striated muscle. J. Mol. Biol 7, 281–308 (1963). [DOI] [PubMed] [Google Scholar]
- 3.Hooijman P, Stewart MA & Cooke R A new state of cardiac myosin with very slow ATP turnover: a potential cardioprotective mechanism in the heart. Biophys. J 100, 1969–1976, doi:S0006–3495(11)00326–2 [pii]; 10.1016/j.bpj.2011.02.061 [doi] (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.de Tombe PP et al. Myofilament length dependent activation. J Mol Cell Cardiol 48, 851–858, doi: 10.1016/j.yjmcc.2009.12.017 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Alamo L et al. Effects of myosin variants on interacting-heads motif explain distinct hypertrophic and dilated cardiomyopathy phenotypes. Elife 6, doi: 10.7554/eLife.24634 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Nag S et al. The myosin mesa and the basis of hypercontractility caused by hypertrophic cardiomyopathy mutations. Nat Struct Mol Biol 24, 525–533, doi: 10.1038/nsmb.3408 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Geeves MA & Holmes KC Structural mechanism of muscle contraction. Annu. Rev. Biochem 68, 687–728 (1999). [DOI] [PubMed] [Google Scholar]
- 8.Kensler RW The mammalian cardiac muscle thick filament: crossbridge arrangement. J. Struct. Biol 149, 303–312, doi:S1047–8477(05)00004–3 [pii]; 10.1016/j.jsb.2004.12.003[doi] (2005). [DOI] [PubMed] [Google Scholar]
- 9.Craig R & Woodhead JL Structure and function of myosin filaments. Curr Opin Struct Biol 16, 204–212, doi: 10.1016/j.sbi.2006.03.006 (2006). [DOI] [PubMed] [Google Scholar]
- 10.Wendt T, Taylor D, Trybus KM & Taylor K Three-dimensional image reconstruction of dephosphorylated smooth muscle heavy meromyosin reveals asymmetry in the interaction between myosin heads and placement of subfragment 2. Proc. Natl. Acad. Sci. U. S. A 98, 4361–4366 (2001). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Woodhead JL et al. Atomic model of a myosin filament in the relaxed state. Nature 436, 1195–1199 (2005). [DOI] [PubMed] [Google Scholar]
- 12.Alamo L et al. Three-dimensional reconstruction of tarantula myosin filaments suggests how phosphorylation may regulate myosin activity. J. Mol. Biol 384, 780–797 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Lee KH et al. Interacting-heads motif has been conserved as a mechanism of myosin II inhibition since before the origin of animals. Proc Natl Acad Sci U S A 115, E1991–E2000, doi: 10.1073/pnas.1715247115 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Nelson S, Beck-Previs S, Sadayappan S, Tong C & Warshaw DM Myosin-binding protein C stabilizes, but is not the sole determinant of SRX myosin in cardiac muscle. J Gen Physiol 155, doi: 10.1085/jgp.202213276 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Cooke R The role of the myosin ATPase activity in adaptive thermogenesis by skeletal muscle. Biophys Rev 3, 33–45, doi: 10.1007/s12551-011-0044-9 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Anderson RL et al. Deciphering the super relaxed state of human beta-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers. Proc Natl Acad Sci U S A 115, E8143–E8152, doi: 10.1073/pnas.1809540115 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Zoghbi ME, Woodhead JL, Moss RL & Craig R Three-dimensional structure of vertebrate cardiac muscle myosin filaments. Proc Natl Acad Sci U S A 105, 2386–2390, doi: 10.1073/pnas.0708912105 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Al-Khayat HA, Kensler RW, Squire JM, Marston SB & Morris EP Atomic model of the human cardiac muscle myosin filament. Proc. Natl. Acad. Sci. U. S. A 110, 318–323, doi:1212708110 [pii]; 10.1073/pnas.1212708110 [doi] (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Tamborrini D et al. In situ structures from relaxed cardiac myofibrils reveal the organization of the muscle thick filament. Nature (2023). [Google Scholar]
- 20.Padron R, Dutta D & Craig R Variants of the myosin interacting-heads motif. J Gen Physiol 155, doi: 10.1085/jgp.202213249 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Hu Z, Taylor DW, Reedy MK, Edwards RJ & Taylor KA Structure of myosin filaments from relaxed Lethocerus flight muscle by cryo-EM at 6 A resolution. Sci Adv 2, e1600058, doi: 10.1126/sciadv.1600058 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Koubassova NA et al. Interacting-heads motif explains the X-ray diffraction pattern of relaxed vertebrate skeletal muscle. Biophys J 121, 1354–1366, doi: 10.1016/j.bpj.2022.03.023 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.McLachlan AD & Karn J Periodic charge distributions in the myosin rod amino acid sequence match cross-bridge spacings in muscle. Nature 299, 226–231, doi: 10.1038/299226a0 (1982). [DOI] [PubMed] [Google Scholar]
- 24.Taylor KC et al. Skip residues modulate the structural properties of the myosin rod and guide thick filament assembly. Proc Natl Acad Sci U S A 112, E3806–3815, doi: 10.1073/pnas.1505813112 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Wray JS Structure of the backbone in myosin filaments of muscle. Nature 277, 37–40 (1979). [DOI] [PubMed] [Google Scholar]
- 26.Squire JM General model of myosin filament structure. 3. Molecular packing arrangements in myosin filaments. J. Mol. Biol 77, 291–323 (1973). [DOI] [PubMed] [Google Scholar]
- 27.Gregorio CC, Granzier H, Sorimachi H & Labeit S Muscle assembly: a titanic achievement? Curr. Opin. Cell Biol 11, 18–25 (1999). [DOI] [PubMed] [Google Scholar]
- 28.Tskhovrebova L et al. Shape and flexibility in the titin 11-domain super-repeat. J Mol Biol 397, 1092–1105, doi: 10.1016/j.jmb.2010.01.073 (2010). [DOI] [PubMed] [Google Scholar]
- 29.Harris SP, Lyons RG & Bezold KL In the thick of it: HCM-causing mutations in myosin binding proteins of the thick filament. Circ. Res 108, 751–764, doi:108/6/751 [pii]; 10.1161/CIRCRESAHA.110.231670 [doi] (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Flashman E, Redwood C, Moolman-Smook J & Watkins H Cardiac myosin binding protein C: its role in physiology and disease. Circ. Res 94, 1279–1289 (2004). [DOI] [PubMed] [Google Scholar]
- 31.Granzier HL & Labeit S The giant protein titin: a major player in myocardial mechanics, signaling, and disease. Circ Res 94, 284–295, doi: 10.1161/01.RES.0000117769.88862.F8 (2004). [DOI] [PubMed] [Google Scholar]
- 32.Bucher RM, Svergun DI, Muhle-Goll C & Mayans O The structure of the FnIII Tandem A77-A78 points to a periodically conserved architecture in the myosin-binding region of titin. J Mol Biol 401, 843–853, doi: 10.1016/j.jmb.2010.06.011 (2010). [DOI] [PubMed] [Google Scholar]
- 33.Lee K, Harris SP, Sadayappan S & Craig R Orientation of myosin binding protein C in the cardiac muscle sarcomere determined by domain-specific immuno-EM. J Mol Biol 427, 274–286, doi: 10.1016/j.jmb.2014.10.023 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Tonino P, Kiss B, Gohlke J, Smith JE 3rd & Granzier H Fine mapping titin’s C-zone: Matching cardiac myosin-binding protein C stripes with titin’s super-repeats. J Mol Cell Cardiol 133, 47–56, doi: 10.1016/j.yjmcc.2019.05.026 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Huxley HE & Brown W The low-angle x-ray diagram of vertebrate striated muscle and its behaviour during contraction and rigor. J. Mol. Biol 30, 383–434 (1967). [DOI] [PubMed] [Google Scholar]
- 36.Sohn RL et al. A 29 residue region of the sarcomeric myosin rod is necessary for filament formation. J. Mol. Biol 266, 317–330 (1997). [DOI] [PubMed] [Google Scholar]
- 37.Houmeida A, Holt J, Tskhovrebova L & Trinick J Studies of the interaction between titin and myosin. J. Cell Biol 131, 1471–1481 (1995). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Muhle-Goll C et al. Structural and functional studies of titin’s fn3 modules reveal conserved surface patterns and binding to myosin S1--a possible role in the Frank-Starling mechanism of the heart. J. Mol. Biol 313, 431–447 (2001). [DOI] [PubMed] [Google Scholar]
- 39.McNamara JW et al. Ablation of cardiac myosin binding protein-C disrupts the super-relaxed state of myosin in murine cardiomyocytes. J Mol Cell Cardiol 94, 65–71, doi: 10.1016/j.yjmcc.2016.03.009 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Heling L, Geeves MA & Kad NM MyBP-C: one protein to govern them all. J Muscle Res Cell Motil 41, 91–101, doi: 10.1007/s10974-019-09567-1 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Luther PK et al. Direct visualization of myosin-binding protein C bridging myosin and actin filaments in intact muscle. Proc Natl Acad Sci U S A 108, 11423–11428, doi: 10.1073/pnas.1103216108 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Reconditi M et al. Sarcomere-length dependence of myosin filament structure in skeletal muscle fibres of the frog. J Physiol 592, 1119–1137, doi: 10.1113/jphysiol.2013.267849 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Freiburg A & Gautel M A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. Eur. J. Biochem 235, 317–323 (1996). [DOI] [PubMed] [Google Scholar]
- 44.Bennett P, Rees M & Gautel M The Axial Alignment of Titin on the Muscle Thick Filament Supports Its Role as a Molecular Ruler. J Mol Biol 432, 4815–4829, doi: 10.1016/j.jmb.2020.06.025 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Craig R & Padron R Structural basis of the super- and hyper-relaxed states of myosin II. J Gen Physiol 154, doi: 10.1085/jgp.202113012 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Grinzato A et al. Cryo-EM structure of the folded-back state of human beta-cardiac myosin. Nat Commun 14, 3166, doi: 10.1038/s41467-023-38698-w (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Lowey S, Saraswat LD, Liu H, Volkmann N & Hanein D Evidence for an interaction between the SH3 domain and the N-terminal extension of the essential light chain in class II myosins. J. Mol. Biol 371, 902–913 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Blankenfeldt W, Thoma NH, Wray JS, Gautel M & Schlichting I Crystal structures of human cardiac beta-myosin II S2-Delta provide insight into the functional role of the S2 subfragment. Proc. Natl. Acad. Sci. U. S. A 103, 17713–17717 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Ait-Mou Y et al. Titin strain contributes to the Frank-Starling law of the heart by structural rearrangements of both thin- and thick-filament proteins. Proc Natl Acad Sci U S A 113, 2306–2311, doi: 10.1073/pnas.1516732113 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Brunello E et al. Myosin filament-based regulation of the dynamics of contraction in heart muscle. Proc Natl Acad Sci U S A 117, 8177–8186, doi: 10.1073/pnas.1920632117 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Alamo L et al. Conserved Intramolecular Interactions Maintain Myosin Interacting-Heads Motifs Explaining Tarantula Muscle Super-Relaxed State Structural Basis. J Mol Biol 428, 1142–1164, doi: 10.1016/j.jmb.2016.01.027 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Ma W et al. The Super-Relaxed State and Length Dependent Activation in Porcine Myocardium. Circ Res 129, 617–630, doi: 10.1161/CIRCRESAHA.120.318647 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Reconditi M et al. Myosin filament activation in the heart is tuned to the mechanical task. Proc Natl Acad Sci U S A 114, 3240–3245, doi: 10.1073/pnas.1619484114 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Irving M Regulation of Contraction by the Thick Filaments in Skeletal Muscle. Biophys J 113, 2579–2594, doi: 10.1016/j.bpj.2017.09.037 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Espinoza-Fonseca LM, Kast D & Thomas DD Molecular dynamics simulations reveal a disorder-to-order transition on phosphorylation of smooth muscle myosin. Biophys J 93, 2083–2090, doi: 10.1529/biophysj.106.095802 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Blair CA et al. A Protocol for Collecting Human Cardiac Tissue for Research. VAD J 2, doi: 10.13023/VAD.2016.12 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Chaponnier C, Janmey PA & Yin HL The actin filament-severing domain of plasma gelsolin. J. Cell Biol 103, 1473–1481 (1986). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Hidalgo C, Padron R, Horowitz R, Zhao FQ & Craig R Purification of native myosin filaments from muscle. Biophys. J 81, 2817–2826 (2001). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Craig R Isolation, electron microscopy and 3D reconstruction of invertebrate muscle myofilaments. Methods 56, 33–43, doi:S1046–2023(11)00239–8 [pii]; 10.1016/j.ymeth.2011.11.007 [doi] (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Mastronarde DN Automated electron microscope tomography using robust prediction of specimen movements. J Struct Biol 152, 36–51, doi: 10.1016/j.jsb.2005.07.007 (2005). [DOI] [PubMed] [Google Scholar]
- 61.Punjani A, Rubinstein JL, Fleet DJ & Brubaker MA cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat Methods 14, 290–296, doi: 10.1038/nmeth.4169 (2017). [DOI] [PubMed] [Google Scholar]
- 62.Sanchez-Garcia R et al. DeepEMhancer: a deep learning solution for cryo-EM volume post-processing. Commun Biol 4, 874, doi: 10.1038/s42003-021-02399-1 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Kidmose RT et al. Namdinator - automatic molecular dynamics flexible fitting of structural models into cryo-EM and crystallography experimental maps. IUCrJ 6, 526–531, doi: 10.1107/S2052252519007619 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Emsley P, Lohkamp B, Scott WG & Cowtan K Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66, 486–501, doi: 10.1107/S0907444910007493 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Jumper J et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589, doi: 10.1038/s41586-021-03819-2 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Liebschner D et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr D Struct Biol 75, 861–877, doi: 10.1107/S2059798319011471 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Lopez-Blanco JR & Chacon P iMODFIT: efficient and robust flexible fitting based on vibrational analysis in internal coordinates. J Struct Biol 184, 261–270, doi: 10.1016/j.jsb.2013.08.010 (2013). [DOI] [PubMed] [Google Scholar]
- 68.Croll TI ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr D Struct Biol 74, 519–530, doi: 10.1107/S2059798318002425 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Williams CJ et al. MolProbity: More and better reference data for improved all-atom structure validation. Protein Sci 27, 293–315, doi: 10.1002/pro.3330 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Pettersen EF et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci 30, 70–82, doi: 10.1002/pro.3943 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Maw MC & Rowe AJ Fraying of A-filaments into three subfilaments. Nature 286, 412–414, doi: 10.1038/286412a0 (1980). [DOI] [PubMed] [Google Scholar]
- 72.Squire JM & Knupp C X-ray diffraction studies of muscle and the crossbridge cycle. Adv. Protein Chem 71, 195–255 (2005). [DOI] [PubMed] [Google Scholar]
- 73.Belus A et al. The familial hypertrophic cardiomyopathy-associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils. J Physiol 586, 3639–3644, doi: 10.1113/jphysiol.2008.155952 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Takezawa Y et al. Backward movements of cross-bridges by application of stretch and by binding of MgADP to skeletal muscle fibers in the rigor state as studied by x-ray diffraction. Biophys. J 76, 1770–1783 (1999). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Woodhead JL & Craig R Through Thick and Thin--Interfilament Communication in Muscle. Biophys J 109, 665–667, doi: 10.1016/j.bpj.2015.07.019 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Brito R et al. A molecular model of phosphorylation-based activation and potentiation of tarantula muscle thick filaments. J. Mol. Biol 414, 44–61, doi:S0022–2836(11)01023–0 [pii]; 10.1016/j.jmb.2011.09.017 [doi] (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Du A, Sanger JM, Linask KK & Sanger JW Myofibrillogenesis in the first cardiomyocytes formed from isolated quail precardiac mesoderm. Dev Biol 257, 382–394, doi: 10.1016/s0012-1606(03)00104-0 (2003). [DOI] [PubMed] [Google Scholar]
- 78.Wood NB, Kelly CM, O’Leary TS, Martin JL & Previs MJ Cardiac Myosin Filaments are Maintained by Stochastic Protein Replacement. Mol Cell Proteomics 21, 100274, doi: 10.1016/j.mcpro.2022.100274 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Structural data that support the findings of this study on the structure of the human cardiac thick filament have been deposited in the Electron Microscopy Data Bank. One 2-crown and two 5-crown maps have been deposited, with accession codes EMD-29734, EMD-29722 and EMD-29726, respectively. An atomic model of the full 3-crown structure, with myosin heads, tails, titins, and cMyBP-C, has been deposited in wwPDB with accession code 8G4L. PDB data used to build the model were PDB 5n69 and PDB 2fxo. AlphaFold structures used to build the model were P10916, P12883, and Q14896.